IBM (IBM) Offering Possible 16.96% Return Over the Next 30 Calendar Days

IBM’s most recent trend suggests a bullish bias. One trading opportunity on IBM is a Bull Put Spread using a strike $140.00 short put and a strike $130.00 long put offers a potential 16.96% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $140.00 by expiration. The full premium credit of $1.45 would be kept by the premium seller. The risk of $8.55 would be incurred if the stock dropped below the $130.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for IBM is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for IBM is bullish.

The RSI indicator is at 75.83 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for IBM

IBM seeks $167 million from Groupon in dispute over early internet patents
Tue, 17 Jul 2018 01:33:21 +0000
International Business Machines Corp on Monday asked a U.S. jury to award it $167 million in a lawsuit accusing e-commerce marketplace operator Groupon Inc of using patented technology without authorization. IBM lawyer John Desmarais told a jury in federal court in Delaware that Groupon infringed patents describing foundational e-commerce technology that had already been licensed to Amazon Inc, Facebook Inc and Alphabet Inc’s Google for between $20 million and $50 million per company.

IBM Seeks $167 Million From Groupon in E-Commerce Patent Suit
Mon, 16 Jul 2018 20:54:36 +0000
Groupon Inc. built its online coupon business on the back of International Business Machines Corp.’s e-commerce inventions without permission, lawyers for IBM said at the start of a federal trial seeking damages for patent infringement. John Desmarais, a lawyer for IBM, said Chicago-based Groupon arrived “relatively late” to e-commerce and piggybacked on existing technologies. Many companies, including Amazon.com Inc. and Facebook Inc., have bought licenses to use the company’s patented technology, while Groupon hasn’t, he said.

What to Know about IBM’s Billion-Dollar Aussie Contract
Mon, 16 Jul 2018 20:46:00 +0000
Earlier this month, IBM (IBM) secured a technology contract with the Australian government worth 1.0 billion Australian dollars ($740 million). The five-year contract involves IBM offering automation services to Australia’s federal departments. In an interview with Bloomberg, IBM Asia-Pacific CEO Harriet Green said the Aussie government stands to save as much as 100 million Australian dollars by awarding IBM the technology contract.

10 Dow Jones Titans to Buy Now
Mon, 16 Jul 2018 19:48:03 +0000
The Dow Jones Industrial Average has climbed back up over the 25,000 level. As a result, a number of big-cap Dow Jones stocks — outside of the technology sector that has been red hot for months — are perking up and looking ready to run higher. The company will next report results on July 25, with analysts looking for earnings of $3.40 per share on revenues of $23.9 billion.

IBM to Beat On Q2 Earnings: ETFs to Watch
Mon, 16 Jul 2018 16:01:04 +0000
These ETFs could be potential movers if IBM surprises the market.

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.